Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Growth (Status and Outlook) 2025-2031

December 2025 | 75 pages | ID: G5901762EC18EN
LP Information

Abstracts

According to this study, the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market size will reach US$ million by 2031.

Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Forecast” looks at past sales and reviews total world Vascular Endothelial Growth Factor (VEGF) Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected Vascular Endothelial Growth Factor (VEGF) Inhibitors sales for 2025 through 2031. With Vascular Endothelial Growth Factor (VEGF) Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Endothelial Growth Factor (VEGF) Inhibitors industry.

This Insight Report provides a comprehensive analysis of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vascular Endothelial Growth Factor (VEGF) Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vascular Endothelial Growth Factor (VEGF) Inhibitors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Endothelial Growth Factor (VEGF) Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Endothelial Growth Factor (VEGF) Inhibitors.

This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Endothelial Growth Factor (VEGF) Inhibitors market by product type, application, key players and key regions and countries.

Segmentation by Type:

• VEGF-A Inhibitor
• VEGF-B Inhibitor
• VEGF-C Inhibitor
• VEGF-D Inhibitor

Segmentation by Application:

• Oncology
• Ophthalmology

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bayer AG
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
• Sanofi.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size (2020-2031)
  2.1.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Vascular Endothelial Growth Factor (VEGF) Inhibitors by Country/Region (2020, 2024 & 2031)
2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Type
  2.2.1 VEGF-A Inhibitor
  2.2.2 VEGF-B Inhibitor
  2.2.3 VEGF-C Inhibitor
  2.2.4 VEGF-D Inhibitor
2.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type
  2.3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2020-2025)
2.4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Segment by Application
  2.4.1 Oncology
  2.4.2 Ophthalmology
2.5 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application
  2.5.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2020-2025)

3 VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS MARKET SIZE BY PLAYER

3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Player
  3.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Player (2020-2025)
  3.1.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Player (2020-2025)
3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS BY REGION

4.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2020-2025)
4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth (2020-2025)
4.4 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth (2020-2025)
4.5 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth (2020-2025)
4.6 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2020-2025)
5.2 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025)
5.3 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2020-2025)
6.2 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025)
6.3 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2020-2025)
7.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025)
7.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors by Region (2020-2025)
8.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025)
8.3 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS MARKET FORECAST

10.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Region (2026-2031)
  10.1.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Region (2026-2031)
  10.1.2 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.1.3 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.1.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.1.5 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.2 Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Country (2026-2031)
  10.2.1 United States Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.2.2 Canada Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.2.3 Mexico Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.2.4 Brazil Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.3 APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Region (2026-2031)
  10.3.1 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast
  10.3.2 Japan Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.3.3 Korea Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.3.4 Southeast Asia Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.3.5 India Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.3.6 Australia Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Country (2026-2031)
  10.4.1 Germany Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.4.2 France Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.4.3 UK Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.4.4 Italy Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.4.5 Russia Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.5 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Region (2026-2031)
  10.5.1 Egypt Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.5.2 South Africa Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.5.3 Israel Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
  10.5.4 Turkey Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast
10.6 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Type (2026-2031)
10.7 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Vascular Endothelial Growth Factor (VEGF) Inhibitors Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bayer AG
  11.1.1 Bayer AG Company Information
  11.1.2 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
  11.1.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bayer AG Main Business Overview
  11.1.5 Bayer AG Latest Developments
11.2 F. Hoffmann-La Roche Ltd.
  11.2.1 F. Hoffmann-La Roche Ltd. Company Information
  11.2.2 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
  11.2.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.3 Novartis AG
  11.3.1 Novartis AG Company Information
  11.3.2 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
  11.3.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Novartis AG Main Business Overview
  11.3.5 Novartis AG Latest Developments
11.4 Regeneron Pharmaceuticals Inc.
  11.4.1 Regeneron Pharmaceuticals Inc. Company Information
  11.4.2 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
  11.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Regeneron Pharmaceuticals Inc. Main Business Overview
  11.4.5 Regeneron Pharmaceuticals Inc. Latest Developments
11.5 Sanofi.
  11.5.1 Sanofi. Company Information
  11.5.2 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
  11.5.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sanofi. Main Business Overview
  11.5.5 Sanofi. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of VEGF-A Inhibitor
Table 4. Major Players of VEGF-B Inhibitor
Table 5. Major Players of VEGF-C Inhibitor
Table 6. Major Players of VEGF-D Inhibitor
Table 7. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2020-2025)
Table 10. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2020-2025)
Table 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Player (2020-2025)
Table 15. Vascular Endothelial Growth Factor (VEGF) Inhibitors Key Players Head office and Products Offered
Table 16. Vascular Endothelial Growth Factor (VEGF) Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region (2020-2025)
Table 21. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Country (2020-2025)
Table 25. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2020-2025)
Table 27. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2020-2025)
Table 29. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region (2020-2025)
Table 31. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Country (2020-2025)
Table 35. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 41. Key Market Challenges & Risks of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 42. Key Industry Trends of Vascular Endothelial Growth Factor (VEGF) Inhibitors
Table 43. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Bayer AG Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 48. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 49. Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Bayer AG Main Business
Table 51. Bayer AG Latest Developments
Table 52. F. Hoffmann-La Roche Ltd. Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 53. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 54. F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. F. Hoffmann-La Roche Ltd. Main Business
Table 56. F. Hoffmann-La Roche Ltd. Latest Developments
Table 57. Novartis AG Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 58. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 59. Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Novartis AG Main Business
Table 61. Novartis AG Latest Developments
Table 62. Regeneron Pharmaceuticals Inc. Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 63. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 64. Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Regeneron Pharmaceuticals Inc. Main Business
Table 66. Regeneron Pharmaceuticals Inc. Latest Developments
Table 67. Sanofi. Details, Company Type, Vascular Endothelial Growth Factor (VEGF) Inhibitors Area Served and Its Competitors
Table 68. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
Table 69. Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Sanofi. Main Business
Table 71. Sanofi. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Country/Region (2024)
Figure 8. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type in 2024
Figure 10. Vascular Endothelial Growth Factor (VEGF) Inhibitors in Oncology
Figure 11. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Oncology (2020-2025) & ($ millions)
Figure 12. Vascular Endothelial Growth Factor (VEGF) Inhibitors in Ophthalmology
Figure 13. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Ophthalmology (2020-2025) & ($ millions)
Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application in 2024
Figure 15. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue Market Share by Player in 2024
Figure 16. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region (2020-2025)
Figure 17. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2020-2025 ($ millions)
Figure 18. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2020-2025 ($ millions)
Figure 19. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2020-2025 ($ millions)
Figure 21. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Value Market Share by Country in 2024
Figure 22. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region in 2024
Figure 27. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2020-2025)
Figure 28. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2020-2025)
Figure 29. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 33. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Country in 2024
Figure 36. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2020-2025)
Figure 37. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2020-2025)
Figure 38. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 39. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 52. APAC Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 53. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 55. United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 56. Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 57. Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 58. Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 59. China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 60. Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 61. Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 63. India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 64. Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 65. Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 66. France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 67. UK Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 68. Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 69. Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 70. Egypt Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 71. South Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 72. Israel Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 73. Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)
Figure 74. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size 2026-2031 ($ millions)